- Easy Tracking In The Watchlist
Corbus Pharmaceuticals Holdings stock price down 0.221% on Wednesday
(Updated on Jul 15, 2026)
The Corbus Pharmaceuticals Holdings stock price fell by -0.221% on the last day (Wednesday, 15th Jul 2026) from $9.03 to $9.01. It has now fallen 3 days in a row. During the last trading day the stock fluctuated 4.09% from a day low at $8.80 to a day high of $9.16. The price has been going up and down for this period, and there has been a -3.94% loss for the last 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -26 thousand shares and in total, 273 thousand shares were bought and sold for approximately $2.46 million.
The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -18.16% during the next 3 months and, with a 90% probability hold a price between $5.16 and $8.63 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.
CRBP Signals & Forecast
The Corbus Pharmaceuticals Holdings stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $9.34. On a fall, the stock will find some support from the long-term average at approximately $8.40. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Friday, July 10, 2026, and so far it has fallen -6.92%. Further fall is indicated until a new bottom pivot has been found. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.
Support, Risk & Stop-loss for Corbus Pharmaceuticals Holdings stock
Corbus Pharmaceuticals Holdings finds support from accumulated volume at $8.74 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.360 between high and low, or 4.09%. For the last week, the stock has had daily average volatility of 4.88%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (CRBP) For The Upcoming Trading Day Of Thursday 16th
For the upcoming trading day on Thursday, 16th we expect Corbus Pharmaceuticals Holdings to open at $8.99, and during the day (based on 14 day Average True Range), to move between $8.75 and $9.27, which gives a possible trading interval of +/-$0.518 (+/-5.92%) up or down from last closing price. If Corbus Pharmaceuticals Holdings takes out the full calculated possible swing range there will be an estimated 5.92% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $8.74 (3.00%) than the resistance at $9.38 (4.11%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Is Corbus Pharmaceuticals Holdings stock A Buy?
Corbus Pharmaceuticals Holdings holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.
Current score:
-2.615
Sell Candidate
Unchanged
Predicted Fair Opening Price
Predicted fair opening price on July 16, 2026 - $8.99 ( 0.222%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
CRBP Performance
Trading levels for CRBP
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 9.35 | 3.77% |
| R2 | 9.21 | 2.25% |
| R1 | 9.13 | 1.30% |
| Price | 9.01 | |
| S1 | 8.85 | -1.75% |
| S2 | 8.77 | -2.69% |
| S3 | 8.63 | -4.22% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 10.92 | 21.20% |
| R2 | 9.82 | 8.99% |
| R1 | 9.38 | 4.11% |
| Price | 9.01 | |
| S1 | 8.74 | -3.00% |
| S2 | 7.91 | -12.21% |
| S3 | 7.82 | -13.21% |
FAQ
Click here for our free guide on how to buy Corbus Pharmaceuticals Holdings Stock.
Buy CRBP